AGIOS PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

04 أبريل 2025 09:58:04 بحسب NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

01 أبريل 2025 13:49:16 بحسب NetDania Notify

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

05 مارس 2025 17:52:45 بحسب Nasdaq GlobeNewswire

Agios to Present at Upcoming Investor Conferences

04 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

20 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

13 فبراير 2025 06:31:00 بحسب Nasdaq GlobeNewswire

Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

13 فبراير 2025 06:30:00 بحسب Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

06 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

13 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia

08 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

03 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease

18 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

08 ديسمبر 2024 12:40:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

11 نوفمبر 2024 09:45:31 بحسب NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

08 نوفمبر 2024 09:55:39 بحسب NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

07 نوفمبر 2024 14:59:27 بحسب NetDania Notify

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

05 نوفمبر 2024 09:05:00 بحسب Nasdaq GlobeNewswire

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

31 أكتوبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease

23 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

17 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire